Unraveling the nexus between cellular senescence and malignant transformation: a paradigm shift in cancer research

References

1. 1.↵
   2. Li X,
   3. Xu H,
   4. Xu C,
   5. Lin M,
   6. Song X,
   7. Yi F, et al.

   The yin-yang of DNA damage response: roles in tumorigenesis and cellular senescence. Int J Mol Sci. 2013; 14: 2431–48.

   OpenUrlCrossRefPubMed
2. 2.↵
   2. Cao L,
   3. Kim S,
   4. Xiao C,
   5. Wang RH,
   6. Coumoul X,
   7. Wang X, et al.

   ATM-Chk2-p53 activation prevents tumorigenesis at an expense of organ homeostasis upon BRCA1 deficiency. EMBO J. 2006; 25: 2167–77.

   OpenUrlAbstract/FREE Full Text
3. 3.↵
   2. Cao L,
   3. Li W,
   4. Kim S,
   5. Brodie SG,
   6. Deng CX.

   Senescence, aging, and malignant transformation mediated by p53 in mice lacking the BRCA1 full-length isoform. Genes Dev. 2003; 17: 201–13.

   OpenUrlAbstract/FREE Full Text
4. 4.↵
   2. Colucci M,
   3. Zumerle S,
   4. Bressan S,
   5. Gianfanti F,
   6. Troiani M,
   7. Valdata A, et al.

   Retinoic acid receptor activation reprograms senescence response and enhances anti-tumor activity of natural killer cells. Cancer Cell. 2024; 42: 646–61.e9.

   OpenUrl
5. 5.↵
   2. Chibaya L,
   3. Murphy KC,
   4. DeMarco KD,
   5. Gopalan S,
   6. Liu H,
   7. Parikh CN, et al.

   EZH2 inhibition remodels the inflammatory senescence-associated secretory phenotype to potentiate pancreatic cancer immune surveillance. Nature Cancer. 2023; 4: 872–92.

   OpenUrl
6. 6.↵
   2. Acosta JC,
   3. O’Loghlen A,
   4. Banito A,
   5. Guijarro MV,
   6. Augert A,
   7. Raguz S, et al.

   Chemokine signaling via the CXCR2 receptor reinforces senescence. Cell. 2008; 133: 1006–18.

   OpenUrlCrossRefPubMedWeb of Science
7. 7.↵
   2. Lawrenson K,
   3. Grun B,
   4. Benjamin E,
   5. Jacobs IJ,
   6. Dafou D,
   7. Gayther SA.

   Senescent fibroblasts promote neoplastic transformation of partially transformed ovarian epithelial cells in a three-dimensional model of early stage ovarian cancer. Neoplasia (New York, NY). 2010; 12: 317–25.

   OpenUrlCrossRefPubMedWeb of Science
8. 8.↵
   2. Han L,
   3. Long Q,
   4. Li S,
   5. Xu Q,
   6. Zhang B,
   7. Dou X, et al.

   Senescent stromal cells promote cancer resistance through SIRT1 loss-potentiated overproduction of small extracellular vesicles. Cancer Res. 2020; 80: 3383–98.

   OpenUrlAbstract/FREE Full Text
9. 9.↵
   2. Guccini I,
   3. Revandkar A,
   4. D’Ambrosio M,
   5. Colucci M,
   6. Pasquini E,
   7. Mosole S, et al.

   Senescence reprogramming by TIMP1 deficiency promotes prostate cancer metastasis. Cancer Cell. 2021; 39: 68–82.e9.

   OpenUrlCrossRef
10. 10.↵
    2. Jeon HM,
    3. Kim JY,
    4. Cho HJ,
    5. Lee WJ,
    6. Nguyen D,
    7. Kim SS, et al.

    Tissue factor is a critical regulator of radiation therapy-induced glioblastoma remodeling. Cancer Cell. 2023; 41: 1480–97.e9.

    OpenUrlCrossRef
11. 11.
    2. Yamagishi R,
    3. Kamachi F,
    4. Nakamura M,
    5. Yamazaki S,
    6. Kamiya T,
    7. Takasugi M, et al.

    Gasdermin D-mediated release of IL-33 from senescent hepatic stellate cells promotes obesity-associated hepatocellular carcinoma. Sci Immunol. 2022; 7: eabl7209.
12. 12.↵
    2. Hwang HJ,
    3. Lee YR,
    4. Kang D,
    5. Lee HC,
    6. Seo HR,
    7. Ryu JK, et al.

    Endothelial cells under therapy-induced senescence secrete CXCL11, which increases aggressiveness of breast cancer cells. Cancer Lett. 2020; 490: 100–10.

    OpenUrlCrossRef
13. 13.↵
    2. Kim SS,
    3. Cao L,
    4. Li C,
    5. Xu X,
    6. Huber LJ,
    7. Chodosh LA, et al.

    Uterus hyperplasia and increased carcinogen-induced tumorigenesis in mice carrying a targeted mutation of the Chk2 phosphorylation site in BRCA1. Mol Cell Biol. 2004; 24: 9498–507.

    OpenUrlAbstract/FREE Full Text
14. 14.↵
    2. Yizhak K,
    3. Aguet F,
    4. Kim J,
    5. Hess JM,
    6. Kübler K,
    7. Grimsby J, et al.

    RNA sequence analysis reveals macroscopic somatic clonal expansion across normal tissues. Science (New York, N.Y.). 2019; 364: eaaw0726.
15. 15.↵
    2. Horvath S.

    DNA methylation age of human tissues and cell types. Genome Biol. 2013; 14: R115.
16. 16.↵
    2. Cheng Y,
    3. Cao L.

    Autophagy and tumor cell death. Adv Exp Med Biol. 2020; 1207: 339–49.

    OpenUrl
17. 17.↵
    2. Liu J,
    3. Lu S,
    4. Zheng L,
    5. Guo Q,
    6. Cao L,
    7. Xiao Y, et al.

    ATM-CHK2-TRIM32 axis regulates ATG7 ubiquitination to initiate autophagy under oxidative stress. Cell Rep. 2023; 42: 113402.
18. 18.
    2. Guo QQ,
    3. Wang SS,
    4. Zhang SS,
    5. Xu HD,
    6. Li XM,
    7. Guan Y, et al.

    ATM-CHK2-Beclin 1 axis promotes autophagy to maintain ROS homeostasis under oxidative stress. EMBO J. 2020; 39: e103111.
19. 19.↵
    2. Guo R,
    3. Wang SS,
    4. Jiang XY,
    5. Zhang Y,
    6. Guo Y,
    7. Cui HY, et al.

    CHK2 promotes metabolic stress-induced autophagy through ULK1 phosphorylation. Antioxidants (Basel, Switzerland). 2022; 11: 1166.

    OpenUrl
20. 20.↵
    2. Chen Y,
    3. Wu J,
    4. Zhai L,
    5. Zhang T,
    6. Yin H,
    7. Gao H, et al.

    Metabolic regulation of homologous recombination repair by MRE11 lactylation. Cell. 2024; 187: 294–311.e21.

    OpenUrl
21. 21.↵
    2. Meng H,
    3. Cao Y,
    4. Qin J,
    5. Song X,
    6. Zhang Q,
    7. Shi Y, et al.

    DNA methylation, its mediators and genome integrity. Int J Biol Sci. 2015; 11: 604–17.

    OpenUrlCrossRefPubMed
22. 22.↵
    2. Yi F,
    3. Zhang Y,
    4. Wang Z,
    5. Wang Z,
    6. Li Z,
    7. Zhou T, et al.

    The deacetylation-phosphorylation regulation of SIRT2-SMC1A axis as a mechanism of antimitotic catastrophe in early tumorigenesis. Sci Adv. 2021; 7: eabe5518.
23. 23.↵
    2. Xiao C,
    3. Sharp JA,
    4. Kawahara M,
    5. Davalos AR,
    6. Difilippantonio MJ,
    7. Hu Y, et al.

    The XIST noncoding RNA functions independently of BRCA1 in X inactivation. Cell. 2007; 128: 977–89.

    OpenUrlCrossRefPubMedWeb of Science
24. 24.↵
    2. Xu Q,
    3. Long Q,
    4. Zhu D,
    5. Fu D,
    6. Zhang B,
    7. Han L, et al.

    Targeting amphiregulin (AREG) derived from senescent stromal cells diminishes cancer resistance and averts programmed cell death 1 ligand (PD-L1)-mediated immunosuppression. Aging Cell. 2019; 18: e13027.
25. 25.↵
    2. Jiang X,
    3. Loayza-Puch F.

    Roles of eIF5A in the immunosurveillance of cellular senescence. Cancer Biol Med. 2022; 19: 1523–7.

    OpenUrlFREE Full Text
26. 26.↵
    2. Haston S,
    3. Gonzalez-Gualda E,
    4. Morsli S,
    5. Ge J,
    6. Reen V,
    7. Calderwood A, et al.

    Clearance of senescent macrophages ameliorates tumorigenesis in KRAS-driven lung cancer. Cancer Cell. 2023; 41: 1242–60.e6.

    OpenUrlCrossRef
27. 27.↵
    2. Fan G,
    3. Yu B,
    4. Tang L,
    5. Zhu R,
    6. Chen J,
    7. Zhu Y, et al.

    TSPAN8(+) myofibroblastic cancer-associated fibroblasts promote chemoresistance in patients with breast cancer. Sci Transl Med. 2024; 16: eadj5705.
28. 28.↵
    2. Saleh T,
    3. Bloukh S,
    4. Carpenter VJ,
    5. Alwohoush E,
    6. Bakeer J,
    7. Darwish S, et al.

    Therapy-induced senescence: an “old” friend becomes the enemy. Cancers. 2020; 12: 822.

    OpenUrl
29. 29.↵
    2. Soriani A,
    3. Zingoni A,
    4. Cerboni C,
    5. Iannitto ML,
    6. Ricciardi MR,
    7. Di Gialleonardo V, et al.

    ATM-ATR-dependent up-regulation of DNAM-1 and NKG2D ligands on multiple myeloma cells by therapeutic agents results in enhanced NK-cell susceptibility and is associated with a senescent phenotype. Blood. 2009; 113: 3503–11.

    OpenUrlAbstract/FREE Full Text
30. 30.↵
    2. Ruscetti M,
    3. Morris JPt,
    4. Mezzadra R,
    5. Russell J,
    6. Leibold J,
    7. Romesser PB, et al.

    Senescence-induced vascular remodeling creates therapeutic vulnerabilities in pancreas cancer. Cell. 2020; 181: 424–41.e21.

    OpenUrlCrossRef